131 related articles for article (PubMed ID: 20931242)
1. NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences.
Tosi G; Bondioli L; Ruozi B; Badiali L; Severini GM; Biffi S; De Vita A; Bortot B; Dolcetta D; Forni F; Vandelli MA
J Neural Transm (Vienna); 2011 Jan; 118(1):145-53. PubMed ID: 20931242
[TBL] [Abstract][Full Text] [Related]
2. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
[TBL] [Abstract][Full Text] [Related]
3. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
4. Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments.
Tosi G; Vilella A; Veratti P; Belletti D; Pederzoli F; Ruozi B; Vandelli MA; Zoli M; Forni F
Mol Pharm; 2015 Oct; 12(10):3672-84. PubMed ID: 26312414
[TBL] [Abstract][Full Text] [Related]
5. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.
Vilella A; Tosi G; Grabrucker AM; Ruozi B; Belletti D; Vandelli MA; Boeckers TM; Forni F; Zoli M
J Control Release; 2014 Jan; 174():195-201. PubMed ID: 24316476
[TBL] [Abstract][Full Text] [Related]
6. Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport.
Tosi G; Vilella A; Chhabra R; Schmeisser MJ; Boeckers TM; Ruozi B; Vandelli MA; Forni F; Zoli M; Grabrucker AM
J Control Release; 2014 Mar; 177():96-107. PubMed ID: 24417968
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
8. Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy.
Pascolo L; Bortot B; Benseny-Cases N; Gianoncelli A; Tosi G; Ruozi B; Rizzardi C; De Martino E; Vandelli MA; Severini GM
Int J Nanomedicine; 2014; 9():2791-801. PubMed ID: 24944512
[TBL] [Abstract][Full Text] [Related]
9. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
[TBL] [Abstract][Full Text] [Related]
10. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
[TBL] [Abstract][Full Text] [Related]
11. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
[TBL] [Abstract][Full Text] [Related]
12. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
13. Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.
Salvalaio M; Rigon L; Belletti D; D'Avanzo F; Pederzoli F; Ruozi B; Marin O; Vandelli MA; Forni F; Scarpa M; Tomanin R; Tosi G
PLoS One; 2016; 11(5):e0156452. PubMed ID: 27228099
[TBL] [Abstract][Full Text] [Related]
14. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye.
Raut SL; Kirthivasan B; Bommana MM; Squillante E; Sadoqi M
Nanotechnology; 2010 Oct; 21(39):395102. PubMed ID: 20820096
[TBL] [Abstract][Full Text] [Related]
15. Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization.
Zhang E; Zhukova V; Semyonkin A; Osipova N; Malinovskaya Y; Maksimenko O; Chernikov V; Sokolov M; Grigartzik L; Sabel BA; Gelperina S; Henrich-Noack P
Eur J Pharm Biopharm; 2020 May; 150():131-142. PubMed ID: 32151727
[TBL] [Abstract][Full Text] [Related]
16. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
18. Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake.
Musumeci T; Pellitteri R; Spatuzza M; Puglisi G
J Pharm Sci; 2014 Feb; 103(2):628-35. PubMed ID: 24395679
[TBL] [Abstract][Full Text] [Related]
19. Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice.
Basarkar A; Singh J
Pharm Res; 2009 Jan; 26(1):72-81. PubMed ID: 18779928
[TBL] [Abstract][Full Text] [Related]
20. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies.
Halder KK; Mandal B; Debnath MC; Bera H; Ghosh LK; Gupta BK
J Drug Target; 2008 May; 16(4):311-20. PubMed ID: 18446610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
